The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
Open accessAbstract
Pathological expression of human ErbB-2 protein, also known as HER-2, is common in many types of cancer. ErbB-2 is a member of the EGF receptor tyrosine kinase family and has been rigorously studied as a signaling molecule on the cell membrane. Here, we report that ErbB-2 is also expressed in the nucleus in cultured cells as well as primary tumor tissues. Nuclear ErbB-2 was found to associate with multiple genomic targets in vivo, including the cyclooxygenase enzyme COX-2 gene promoter. ErbB-2 forms a complex at a specific nucleotide sequence of the COX-2 promoter and is able to stimulate its transcription. This study demonstrates the presence of ErbB-2 in the nucleus and identifies the function of ErbB-2 as a transcriptional regulator.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Graus-Porta, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1647 · Cited by 1,590
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
The EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., & Toyoshima, K. (1986) · Nature · doi:10.1038/319230a0 · Cited by 1,204
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Self-citationγ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase
Ni, C.-Y., Murphy, M. P., Golde, T. E., & Carpenter, G. (2001) · Science · doi:10.1126/science.1065412 · Cited by 856
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Ristimaki, A. P., Sivula, A., Lundin, J. E., Lundin, M., Salminen, T. M., Haglund, C. H., Joensuu, H., & Isola, J. J. (2002) · PubMed · Cited by 780
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52976-8 · Cited by 708
A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling
Blagoev, B., Kratchmarova, I., Ong, S.-E., Nielsen, M., Foster, L. J., & Mann, M. (2003) · Nature Biotechnology · doi:10.1038/nbt790 · Cited by 689
Cyclooxygenase-2: A Therapeutic Target
Turini, M. E., & DuBois, R. N. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103952 · Cited by 683
The ErbB receptors and their role in cancer progression
Holbro, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00099-x · Cited by 608
The transcriptional role of PML and the nuclear body
Zhong, S., Salomoni, P., & Pandolfi, P. P. (2000) · Nature Cell Biology · doi:10.1038/35010583 · Cited by 577
The development of COX2 inhibitors
Flower, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1034 · Cited by 459
Hata, A., Seoane, J., Lagna, G., Montalvo, E., Hemmati-Brivanlou, A., & Massagué, J. (2000) · Cell · doi:10.1016/s0092-8674(00)81561-5 · Cited by 420
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half, E., Tang, X., Gwyn, K. M., Şahin, A. A., Wathen, K., & Sinicrope, F. A. (2002) · PubMed · Cited by 384
Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters
Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q., & Farnham, P. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6820-6832.2001 · Cited by 384
The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis
Gately, S. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026575610124 · Cited by 359
Klapper, L. N., Waterman, H., Sela, M., & Yarden, Y. (2000) · PubMed · Cited by 351
Will, H., & Hinzmann, B. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0602d.x · Cited by 336
Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence.
Berry, M., Nunez, A. M., & Chambon, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1218 · Cited by 327
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
Howe, L. R., Subbaramaiah, K., Brown, A. M., & Dannenberg, A. J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080097 · Cited by 322
Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer
Subbaramaiah, K., Norton, L., Gerald, W., & Dannenberg, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111415200 · Cited by 317
Variation in Gene Expression Patterns in Human Gastric Cancers
Chen, X., Leung, S. Y., Yuen, S. T., Chu, K.-M., Ji, J., Li, R., Chan, A. S. Y., Law, S., Troyanskaya, O. G., Wong, J., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0833 · Cited by 316
Tan, M., Yao, J., & Yu, D. (1997) · PubMed · Cited by 261
Importin β–Mediated Nuclear Import of Fibroblast Growth Factor Receptor
Reilly, J. F., & Maher, P. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1307 · Cited by 231
Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2.
Maher, P. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.2.529 · Cited by 224
Regulation of Cyclooxygenase-2 pathway by HER2 receptor
Vadlamudi, R., Mandal, M., Adam, L., Steinbach, G., Mendelsohn, J., & Kumar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202307 · Cited by 222
ErbB-targeted therapeutic approaches in human cancer
Arteaga, C. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00104-0 · Cited by 215
Feng, Y., Venema, V. J., Venema, R. C., Tsai, N., & Caldwell, R. B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9790 · Cited by 208
Offterdinger, M., Schöfer, C., Weipoltshammer, K., & Grunt, T. W. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109033 · Cited by 208
Endo, K., Yoon, B.-I., Pairojkul, C., Demetris, A. J., & Sirica, A. E. (2002) · Hepatology · doi:10.1053/jhep.2002.34435 · Cited by 188
Nuclear localization and possible functions of receptor tyrosine kinases
Carpenter, G. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00015-2 · Cited by 169
Signalling shortcuts: cell-surface receptors in the nucleus?
Wells, A. H., & Marti, U. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm905 · Cited by 150
Xie, Y., & Hung, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2368 · Cited by 134
Self-citationKimura, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2165 · Cited by 94
Abe, Y., Matsumoto, S., Wei, S., Nezu, K., Miyoshi, A., Kito, K., Ueda, N., Shigemoto, K., Hitsumoto, Y., Nikawa, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105669200 · Cited by 84
Takahashi, Y., Kawahara, F., Noguchi, M., Miwa, K., Sato, H., Seiki, M., Inoue, H., Tanabe, T., & Yoshimoto, T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01328-9 · Cited by 78
Fanconi anaemia proteins: Major roles in cell protection against oxidative damage
Pagano, G., & Youssoufian, H. (2003) · BioEssays · doi:10.1002/bies.10283 · Cited by 74
A Human Gene (DDX10) Encoding a Putative DEAD-Box RNA Helicase at 11q22–q23
Savitsky, K., Ziv, Y., Bar‐Shira, A., et al. (1996) · Genomics · doi:10.1006/geno.1996.0184 · Cited by 59
Molecular biology of Fanconi anaemia—an old problem, a new insight
Ahmad, S., Hanaoka, F., & Kirk, S. H. (2002) · BioEssays · doi:10.1002/bies.10082 · Cited by 39
Clevenger, C. V. (2003) · Breast Cancer Research · doi:10.1186/bcr601 · Cited by 36
Cited by
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210477 · Cited by 1,219
Targeting the EGFR signaling pathway in cancer therapy
Seshacharyulu, P., Ponnusamy, M. P., Haridas, D., Jain, M., Ganti, A. K., & Batra, S. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.648617 · Cited by 913
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Wieduwilt, M. J., & Moasser, M. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7440-8 · Cited by 751
Epidermal Growth Factor Receptor Biology in Head and Neck Cancer
Kalyankrishna, S., & Grandis, J. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8306 · Cited by 747
Metadata
- Authors
- Wang, S.-C., Lien, H.-C., Xia, W., Chen, I.-F., Lo, H.-W., Wang, Z., Ali-Seyed, M., Lee, D.-F., Bartholomeusz, G., Ou-Yang, F., Giri, D. K., & Hung, M.-C.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 6
- Issue
- 3
- Pages
- 251-261
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2023648132
- Cited by
- 305
- References
- 44
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.